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Abstract
The volume of publicly available genomic scale data is increasing. Genomic datasets in public
repositories are annotated with free-text fields describing the pathological state of the studied
sample. These annotations are not mapped to concepts in any ontology, making it difficult to
integrate these datasets across repositories. We have previously developed methods to map text-
annotations of tissue microarrays to concepts in the NCI thesaurus and SNOMED-CT.
In this work we generalize our methods to map text annotations of gene expression datasets to
concepts in the UMLS. We demonstrate the utility of our methods by processing annotations of
datasets in the Gene Expression Omnibus. We demonstrate that we enable ontology-based
querying and integration of tissue and gene expression microarray data. We enable identification
of datasets on specific diseases across both repositories. Our approach provides the basis for
ontology-driven data integration for translational research on gene and protein expression data.
Based on this work we have built a prototype system for ontology based annotation and indexing
of biomedical data. The system processes the text metadata of diverse resource elements such as
gene expression data sets, descriptions of radiology images, clinical-trial reports, and PubMed
article abstracts to annotate and index them with concepts from appropriate ontologies. The key
functionality of this system is to enable users to locate biomedical data resources related to
particular ontology concepts.
Introduction and background
The amount and diversity of genomic scale data has been
steadily increasing for the past several years. This increase
has enabled integrative translational bioinformatics stud-
ies across these datasets [1]. Currently, the predominant
genomic level data is gene expression microarrays.
Recently, other forms of genomic scale measurements
have been gaining acceptance, one of them being Tissue
Microarrays. Tissue Microarrays allow for the immunohis-
tochemical analysis of large numbers of tissue samples
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sion results as well as for predictive pathology [2]. A single
tissue microarray (TMA) paraffin block can contain as
many as 500 different tumors, enabling the screening of
thousands of tumor samples for protein expression using
a few array sections [3]. Databases such as the Stanford
Tissue Microarray Database (TMAD) [4] provide a central
repository for data from TMA's akin to the Stanford Micro-
array Database (SMD) and Gene Expression Omnibus
(GEO) for gene expression arrays.
Currently, it is difficult to integrate the results from gene
expression microarrays and tissue microarrays data types
and several reviews have suggested that it is essential to
address this issue and synchronize the analysis, interpre-
tation and data standards for these data [3,5]. In order to
develop integrative approaches to interpret gene and pro-
tein expression datasets, there is a strong and pressing
need to be able to identify all experiments that study a
particular disease. A key query dimension for such integra-
tive studies is the sample, along with a gene or protein
name. As a result, besides queries that identify all genes
that have a function X – which can be reliably answered
using the Gene Ontology (GO) – we need to conduct que-
ries that find all samples/experiments that study a partic-
ular disease and/or the effect of an experimental agent.
However, because of the lack of a commonly used ontol-
ogy or vocabulary to describe the diagnosis, disease stud-
ied or experimental agent applied in a given experimental
dataset it is not possible to perform such a query.
The challenge is to create consistent terminology labels for
each experimental dataset that would allow the identifica-
tion of all samples that are of the same type at a given level
of granularity. (e.g., All carcinoma samples versus all Aden-
ocarcinoma in situ of prostate samples, where the former is
at a coarser level of detail). One mechanism of achieving
this objective is to map the text-annotations describing
the diagnoses, pathological state and experimental agents
applied to a particular sample to ontology terms allowing
us to formulate refined or coarse search criteria [6,7].
Butte et al have previously applied a text-parser (Geno-
Text) to determine the phenotypic and experimental con-
text from text annotations of GEO experiments [1]. They
report that text-parsing is still an inefficient method to
extract value from these annotations [8]. In later work,
Butte et al explored the use of PUBMED identifiers of the
publication associated with GEO experiments and their
assigned Medical Subject Headings (MeSH) to identify
disease related experiments [8]. They were able to relate
35% of PUBMED associated GEO series to human dis-
eases. Only half or so of the GEO experiments have
PUBMED identifiers and the remaining are inaccessible to
this approach, possibly necessitating alternative methods
[8].
We have previously developed methods to process such
text-annotations for tissue microarrays and map them to
concepts in the NCI thesaurus and the SNOMED-CT
ontologies [9,10]. In the current work we generalize our
methods to process text annotations for gene expression
datasets in GEO (as well as TMAD) and map them to con-
cepts in the UMLS. We present results on the accuracy of
our mapping effort and demonstrate how the mapping
enables better query and integration of gene expression
and protein expression data. We discuss the utility of our
approach to derive integrative analyses. We believe that a
similar integration problem exists for other kinds of data
sources: for example, a researcher studying the allelic var-
iations in a gene would want to know all the pathways
that are affected by that gene, the drugs whose effects
could be modulated by the allelic variations in the gene,
and any disease that could be caused by the gene, and the
clinical trials that have studied drugs or diseases related to
that gene. The knowledge needed to study such questions
is available in public biomedical resources; the problem is
finding that information.
Currently most publicly available biomedical data are
annotated with unstructured text and rarely described
with ontology concepts available in the domains. The
challenge is to create consistent terminology labels for
each element in the public resources that would allow the
identification of all elements that relate to the same type
at a given level of granularity. These resource elements
range from experimental data sets in repositories, to
records of disease associations of gene products in muta-
tion databases, to entries of clinical-trial descriptions, to
published papers, and so on. Creating ontology-based
annotations from the textual metadata of the resource ele-
ments will enable end users to formulate flexible searches
for a wider range biomedical data besides just gene expres-
sion arrays and tissue arrays [6,7,9,11]. Therefore, the key
challenge is to automatically and consistently annotate
the biomedical data resource elements to identify the bio-
medical concepts to which they relate. Expanding on our
preliminary work with GEO datasets and tissue microar-
ray annotations, we have built a prototype system for
ontology based annotation and indexing of biomedical
data in the BioPortal ontology repository [12]. The sys-
tem's indexing workflow processes the text metadata of
several biomedical resource elements to annotate (or tag)
them with concepts from appropriate ontologies and cre-
ate an index to access these elements. The key functional-
ity of this system is to enable users to find biomedical data
resources related to particular ontology concepts.
Methods
Overview of annotations in GEO
The Gene Expression Omnibus (GEO) is an international
repository of microarray data run by the National CenterPage 2 of 10
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use the November 2006 release of GEO, which contained
108371 samples, 4593 GEO experiment series and 1080
GEO datasets, 369 of which are human. In this analysis we
focus only on the human datasets. Each GEO dataset has
a title and a description field that contain text entered by
the person uploading the dataset. Moreover, GEO datasets
can have an additional 24 descriptors (such as agent, cell
line, and species) along with their subset descriptions. In
the current work we process the text from the title, descrip-
tion and agent descriptors of GEO datasets.
Overview of text annotations in TMAD
The Stanford Tissue Microarray Database (TMAD) con-
tains data from immunohistochemical analyses per-
formed with tissue microarrays. The TMAD provides tools
for quick upload, storage and retrieval of the tissue micro-
array images and the analysis of immunohistochemical
staining results [13]. Each sample in the TMAD contains
free-text annotations – entered by the experimenter – for
fields such as the organ system, and up to five diagnosis
terms (one principal diagnosis field and four sub diagno-
sis fields) describing the sample. We concatenate the text
from these six fields and use it as the annotation of the
sample for our work. We refer to experiments studying
samples with the same diagnoses as one dataset. Cur-
rently, the TMAD has 10734 samples that can be grouped
into 1045 datasets according to their diagnoses.
Indexing with ontology terms
We downloaded UMLS 2006 AD and created a MySQL
database using the Metamorphosys tool as described in
the UMLS documentation [14].
In order to map existing annotations in TMAD and GEO
to ontology terms, we used the UMLS-Query module
developed by our group to process the existing descrip-
tions of the samples and matching them to ontology
terms. Fully describing the UMLS-Query module and all
of its functionality is beyond the scope of this current
work but we describe the key mapping function mapToId
here. For each text-annotation, we read a sliding window
of five words from the text. We generate all possible per-
mutations (5-grams) of these words and look for an exact
match to an ontology term. We examine all 5 word per-
mutations because we observed that most disease and
drug names are less than 5 words in length. This permuta-
tion based method, though accurate, can be made more
efficient computationally. We are working on that collab-
oratively with the National Center for Integrative Biomed-
ical Informatics [15]. We restrict the matches to
SNOMEDCT and the NCI thesaurus vocabularies when
identifying disease names. The UMLS-Query module
along with detailed documentation is available from [16].
We do not employ any natural language processing strat-
egies such as stemming, normalization or noun-phrase
recognition. We also do not employ any heuristics or
hacks for increasing match accuracy.
The result of the mapping is a table that associates each
GEO or TMAD dataset identifier to one or more concepts
in the UMLS. We query this table to identify disease
related datasets as well as identify matching datasets from
the repositories.
Use of mgrep
For our prototype we used a tool called mgrep [15], devel-
oped by University of Michigan. Mgrep implements a
novel radix tree based data-structure that enables fast and
efficient matching of text against a set of ontology terms.
We use mgrep instead of UMLS-Query in our prototype
because of mgrep is several times faster than UMLS-Query
and the key idea implemented in the mapToId function of
UMLS-Query is also implemented in mgrep.
Architecture of the prototype system
In this section we describe the architecture of the proto-
type consisting of different levels as shown in Figure 1.
The resource level, provides and abstraction for elements of
public biomedical resources (such as GEO and PubMed).
An element is identifiable and can be linked by a specific
URL/URI (id), and it has a structure that defines the meta-
data contexts for the element (title, description, abstract,
and so on). We retrieve the element's text metadata from
resources using public APIs, and keep track of the original
metadata and element id. The annotation level, uses a con-
cept recognition tool called mgrep (developed by Univ. of
Michigan) to annotate (or tag) resource elements with
terms from a dictionary. The dictionary is constructed by
including all the concept names and synonyms from a set
of ontologies accessible to the ontology level. The annota-
tion process keeps track of the context (such as title,
description) from which the annotation was derived. The
results are stored as annotation tables, which contain
information of the form "element E was annotated with con-
cept T in context C". At the index level, a global index com-
bines all the annotation tables to index them by ontology
concepts. The index contains information for the form
"Concept T annotates elements E1, E2,..., En".
We use relations contained in the source ontologies to
expand the annotations. For example, using the is_a rela-
tion, for each term we create additional annotations
according to the parent-child relationships of the original
concept; a process we refer to as the transitive closure of
the annotations. As a result, if a resource element such as
a GEO expression study is annotated with the concept phe-
ochromocytoma from the National Cancer Institute Thesau-
rus (NCIT), then a researcher querying for retroperitoneal
neoplasms can find data sets related to pheochromocytoma.Page 3 of 10
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Architecture of our prototype system comprising of different levelsFigur  1
Architecture of our prototype system comprising of different levels. The figure shows the architecture of the proto-
type consisting of different levels (0). The resource level, provides and abstraction for elements (E1...En) of public biomedical 
resources (such as GEO and PubMed). The annotation level, uses a concept recognition tool called mgrep (developed by Univ. 
of Michigan) to annotate (or tag) resource elements with terms from a dictionary; constructed by including all the concept 
names and synonyms from a set of ontologies accessible to the ontology level. The annotation tables contain information of the 
form "element E was annotated with concept T in context C". At the index level, a global index combines all the annotations to 
index them by ontology concepts and provides information for the form "Concept T annotates elements E1, E2,..., En". See main 
text for details.
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is_a retroperitoneal neoplasms. Creation of annotations
based on transitive closure step is done offline because,
processing the transitive closure is very time consuming –
 even if we use a pre-computed hierarchy – and will result
in prolonged response times for the users. This use case is
similar, in principle, to query expansion done by search
engine like Entrez; however, Entrez does not use the
NCIT, therefore, even though pheochromocytoma related
GEO data sets exist, none show up on searching for retro-
peritoneal neoplasms in Entrez. In our system, however, a
researcher could search for retroperitoneal neoplasms and
find the relevant samples.
At the user level, on searching for a specific ontology con-
cept, the results provide resource elements annotated
directly or via the step of transitive closure. The user
receives the result in terms of references and links (URL/
URI) to the original resource elements. The system archi-
tecture illustrates the generalizability of our implementa-
tion. Note the same model could be applied for domains
other than biomedical informatics. The only specific com-
ponents of the system are the resource access tools (which
are customized for each resource) and, of course, the
ontologies.
Example demonstrating the processing of a GEO dataset 
in the prototype system
A GEO dataset represents a collection of biologically –
and statistically – comparable samples processed using
the same platform. We treat each GEO dataset as a
resource element and process its metadata. Each GEO
dataset has a title and a summary context that contain free
text metadata entered by the person creating the dataset.
For example the GEO dataset 'GDS1989', which is availa-
ble online [17] and can be retrieved using the EUtils API
[18], has the title Melanoma progression. GDS1989's sum-
mary contains the phrase: melanoma in situ. The Human
disease ontology[19], provides the concept Melanoma in
our system's dictionary. Therefore, our concept recogni-
tion tool produces the following annotations:
Element GDS1989 annotated with concept DOID:1909 in
context title;
Element GDS1989 annotated with concept DOID:1909 in
context summary;
The structure of the Human disease ontology shows that
DOID:1909 has 36 direct or indirect parents such as for
instance DOID:169, Neuroendocrine Tumors and DOID:4,
Disease, therefore the transitive closure on the is_a relation
generates the following annotations:
Element GDS1989 annotated with concept DOID:169 with
closure;
Element GDS1989 annotated with concept DOID:4 with clo-
sure;
Results
We processed the annotations corresponding to the anno-
tations of 369 GEO datasets (GDS) and 1045 TMAD data-
sets available at the time this work was conducted. We
then evaluated the ability of our ontology-based indexing
scheme to enable the identification of experiments for the
following use cases: 1) Accurately identify experiments
related to particular diseases 2) Identify gene and protein
expression datasets corresponding to diseases from both
GEO and TMAD. These use cases were defined based on
current research in translational bioinformatics and prior
reviews indicating the need for such integrative analyses
[1-3,8].
Identifying disease related experiments in GEO
Out of 369 GDS, we identify 241 disease related experi-
ments. The 241 disease related experiments can be
grouped into categories according to the semantic type of
 the concepts assigned to them as shown in Table 1. We
exclude high level ontology terms such as cancer, syn-
drome, exposure, damage, toxicity before performing the
grouping. The number of experiments identified as dis-
ease related drops to 209 on removing high level terms.
Such terms, though accurately mapped and being of the
right semantic type, are too high level to enable the correct
identification of disease related datasets.
Table 2 shows examples of the highest and lowest num-
bers of GEO datasets for the Neoplastic Process and Disease
or Syndrome categories. (We omit rows that subsume other
rows, for example leukemia subsumes acute leukemia,
which in turn subsumes acute myeloid leukemia)
Identifying disease related experiments in TMAD
We have previously presented results on processing anno-
tations in TMAD. For the current work, we reprocessed the
records in TMAD and preformed the evaluation as
described before [9]. The average precision and recall was
85% and 95% respectively. The annotations of 1045 data-
sets mapped to 902 disease related concepts in the UMLS.
We do not discuss this further because this has been
described in our previous work [9].
Identifying matching GEO and tissue array datasets
From the 902 disease related datasets in TMAD and 241
disease related GDS that we identified in GEO, we were
able to identify 45 disease related concepts for which there
were datasets in both GEO and TMAD – and hence arePage 5 of 10
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them are high level matches (such as Leukemia) that are
accurate but too high level to enable correlative analyses.
From this set of 45 matches, we identified the 23 disease
related concepts that were at an appropriate level of gran-
ularity and have multiple samples in both GEO and
TMAD to enable further integrative study. In Table 3 we
show the number of datasets, the number of GEO samples
(GSM) and the corresponding number of tissue microar-
ray samples for these.
Evaluation
In order to calculate the precision and recall for the task of
identifying disease related experiments in GEO, we exam
ined the 241 (209 after removing high level terms) GDS
identified as disease related, to determine which of them
were correctly identified. One of the authors (APC), went
through each matched record and scored them for being a
true positive of being a false positive. For calculating
recall, we examined the unmatched GDSs (from the total
of 369 GDSs) and searched the UMLS manually to iden-
tify concept to which the GDSs should have matched; this
allowed us to compute the false negative rate. (Note that
such exhaustive evaluation is not possible with the current
size of GEO, which has over 2000 GDSs). The results of
this evaluation are presented Table 4.
Next, we evaluate the ability to accurately match up the
right tissue array datasets with gene expression datasets.
Out of the 45 candidate datasets proposed as correspond-
ing between GEO and TMAD, on manual inspection all of
them were accurate matches, though 12 were high level
terms such as Cancer, Syndrome, and Sarcoma. We consider
these as false positive because such matched are unin-
formative for the purpose of matching up disease related
datasets across repositories. This gives us a precision of
73%. We were unable to perform a recall analysis for this
task because it is extremely time consuming to manually
examine all the TMAD and GEO datasets to determine the
number of matches that were missed by our method. One
notable disease for which datasets exist in both but were
not accurately identified is Breast carcinoma. Most data-
sets in GEO for this disease are labeled with the term
Breast Cancer (C0006142) and those in TMAD are labeled
with the term Breast carcinoma (C0678222). These terms
Table 1: Categorization of GEO datasets according to the 
Semantic type after excluding matches to high level ontology 
terms.
Semantic type Number of GDS
Neoplastic Process 109
Disease or Syndrome 97
Injury or Poisoning 8
Mental or Behavioral Dysfunction 3
Table 2: Overview of the number of GEO datasets for concepts in the neoplastic process and disease or syndrome category
GDS Concept name CUI Semantic type
Examples of cancers with many GEO datasets
26 Breast cancer C0006142 Neoplastic Process
11 Acute myeloid leukemia C0023467 Neoplastic Process
5 Acute lymphoblastic leukemia C0023449 Neoplastic Process
Examples of cancers with few GEO datasets
1 Kaposi's sarcoma C0036220 Neoplastic Process
1 Acute promyelocytic leukemia C0023487 Neoplastic Process
1 Pleural mesothelioma C1377913 Neoplastic Process
Examples of diseases with many GEO datasets
13 Duchenne dystrophy C0013264 Disease or Syndrome
6 Arthritis C0003864 Disease or Syndrome
4 Chronic obstructive pulmonary disease C0024117 Disease or Syndrome
Examples of diseases with few GEO datasets
1 Open-angle glaucoma C0017612 Disease or Syndrome
1 Purpura thrombocytopenic C0857305 Disease or Syndrome
1 Corneal dystrophy C0010035 Disease or SyndromePage 6 of 10
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ble to match up these datasets.
Integration of the prototype system with NCBO BioPortal
The National Center for Biomedical Ontology (NCBO)
[11] develops and maintains a Web application called
BioPortal to access biomedical ontologies. This library
contains a large collection of ontologies, such as GO,
NCIT, International Classification of Diseases (ICD), in
different formats (OBO, OWL, etc.). Users can browse and
search this repository of ontologies both online and via a
Web services API.
We implemented the first prototype of the system as in the
methods section. We have written a set of Java access tools
to access five resource databases. The resources processed
and the numbers of annotations currently available in our
system are presented in Table 5. A public representational
state transfer (REST) services API [12] is available to query
 the annotations and we have used this API to integrate the
system with BioPortal as shown in Figure 2.
In our prototype, we have processed: (1) gene-expression
data sets from GEO and Array Express, (2) clinical-trial
descriptions from Clinicaltrials.gov, (3) captions of
Table 3: Diseases for which there are both gene expression and tissue microarray datasets
Disease GEO datasets GEO samples TMAD samples
Acute myeloid leukemia 11 366 3
Malignant melanoma 3 47 43
B-cell lymphoma 3 133 27
Prostate cancer 3 47 15
Renal carcinoma 2 34 185
Carcinoma squamous 2 105 175
Multiple myeloma 2 225 169
Clear cell carcinoma 2 34 63
Renal cell carcinoma 2 34 9
Breast carcinoma 2 3 1277
Hepatocellular carcinoma 1 80 163
Carcinoma lung 1 91 66
Cutaneous malignant melanoma 1 38 41
T-cell lymphoma 1 29 31
Lymphoblastic lymphoma 1 29 30
Uterine fibroid 1 10 19
Medulloblastoma 1 46 9
Clear cell sarcoma 1 35 8
Leiomyosarcoma 1 24 5
Mesothelioma 1 54 5
Kaposi's sarcoma 1 4 3
Cardiomyopathy 1 14 2
Dilated cardiomyopathy 1 14 2
Table 4: Accuracy of identifying disease related datasets
Accuracy in identifying disease related datasets
Correct Incorrect Total
Positive 202 (TP) 39 (FP) 241
Negative 97 (TN) 31 (FN) 128
Precision = 83.8% Recall = 86.6%
Accuracy in identifying disease related datasets after limiting high level matches
Correct Incorrect Total
Positive 188 (TP) 21 (FP) 209
Negative 115 (TN) 45 (FN) 160
Precision = 89.9% Recall = 80.6%Page 7 of 10
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of a subset of articles from PubMed. Table 5 shows both
the current number of elements annotated and the
number of annotations created from each resource that
we have processed. Our prototype uses 48 different bio-
medical ontologies that give us 793681 unique concepts
and 2130700 terms. As a result of using such a large
number of terms, our system provides annotations for
almost 100% of the processed resources. The average
number of annotating concepts is between 359 and 769
per element, with an average of 27% of these annotations
resulting from directly recognizing a term. In the current
prototype, concept recognition is done using a tool devel-
oped by National Center for Integrative Biomedical Infor-
matics (NCIBI) called mgrep [20]. We have conducted a
thorough analysis of the accuracy as well as scalability and
flexibility of mgrep in recognizing concepts representing
disease names, body parts and biological processes. The
prototype design of the annotation level is such that we
can plug-in other concept recognizers. The prototype is
available online at [12].
Discussion and future work
In the current work we have processed annotations of tis-
sue microarray samples in TMAD as well as annotations of
gene expression datasets in GEO and mapped them to
concepts in the UMLS. One of the insights in our work is
that disease names are rarely longer than five words and it
is computationally tractable to perform an exhaustive
search for all possible five-word permutations of the text-
annotation.
Mapping text-phrases to UMLS concepts has been per-
formed by other researchers in the past [21,22]. 
Most of these approaches are for the purpose of automatic
indexing of biomedical literature, and have been shown
to be inadequate for processing annotations of high-
throughput datasets [1,8]. It has also been shown that for
the task of identifying concepts from annotations of high-
throughput datasets, simple methods perform equal or
better than Metamap [1,8,10,15]
In the current work, we use very simple methods to proc-
ess text-annotations and map them to ontologies to dem-
onstrate that such automatic mapping enables integration
of gene expression and tissue microarray datasets.
Currently the only way to query the processed annota-
tions is via SQL queries. Performing complicated SQL
queries is not always possible for all end-users and the
ontology hierarchies and the mapped annotations should
drive specialized query-interfaces [9]. 
One possible approach is to process the user's query text
using the same indexing method that mapped the annota-
tions of the datasets and retrieve those datasets that have
the largest intersection with the concepts identified in the
processed query. In future we will develop interfaces to
search these processed annotations as part of our work at
the National Center for Biomedical Ontology, to create
resources and methods to (help biomedical investigators)
Table 5: Number of elements annotated from each resource in the current prototype
Resource Number of elements Resource local size 
(Mb)
Number of direct 
annotations (mgrep 
results)
Total number of 
'useful'1 annotations
Average number of 
annotating concepts
PubMed (subset)
http://
www.ncbi.nlm.nih.gov/
PubMed/
1050000 146.1 30822190 174840027 763
ArrayExpress
http://www.ebi.ac.uk/
arrayexpress/
3371 3.6 502122 1849224 525
ClinicalTrials.gov
http://clinicaltrials.gov/
50303 99 16108580 48796501 824
Gene Expression 
Omnibus
http://
www.ncbi.nlm.nih.gov/
geo/
2085 0.7 165539 772608 359
ARRS GoldMiner 
(subset)
http://
goldminer.arrs.org
1155 0.5 134229 662687 564
TOTAL 1106914 249.9 47732660 226921047 (avg)461.5
1 We do not add a closure annotation between an element and a concept in the index if the given element was already directly annotated with the 
given concept.Page 8 of 10
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research data.
As we all know, genomic scale data is increasing in vol-
ume and diversity. Currently, little attention is being paid
to the problem of developing methods to integrate com-
plementary data types such as gene expression microar-
rays and tissue microarrays based on their annotations
[3,5].
We believe it is possible to perform ontology based index-
ing of free-text annotations of high throughput datasets in
public databases to enable such integration. If the annota-
tions of multiple databases – such as that of GEO, TMAD,
SMD, PharmGKB – are processed in this manner, it will
enable users to perform integrated analyses of multiple,
high throughput, genomic scale dataset s[5]. In order to
demonstrate the feasibility as well as utility of ontology
based indexing, we have developed a prototype system to
annotate elements from public biomedical resources and
enable users to search the indexed resources in an ontol-
ogy driven manner.
Conclusion
We have demonstrated that we can effectively map the
text-annotations of microarray datasets in GEO as well as
annotations of tissue microarrays in TMAD to concepts
from vocabularies in the UMLS. Our results show that we
can map disease names and disease related concepts with
high precision and recall.
User interface within BioPortalFigure 2
User interface within BioPortal. The figure shows the view seen by a user browsing the NCIT in BioPortal and selecting an 
ontology concept (in this case, Hepatocellular carcinoma). The user can see the numbers of online resource elements that relate 
directly to that concept (and the concepts that it subsumes). The interface allows the user to directly access the original ele-
ments that are associated with Hepatocellular carcinoma for each of the indexed resources.Page 9 of 10
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We demonstrate how such mapping to concept hierar-
chies offers the ability to identify corresponding datasets
across different repositories for integrative analyses. We
identified 23 candidate datasets for further study. We have
implemented the mapping functionality as a PERL mod-
ule named UMLS-Query, which is available with docu-
mentation at [16].
We have described a prototype implementation of an
ontology-based annotation and indexing system. The sys-
tem processes text metadata of gene-expression data sets,
descriptions of radiology images, clinical-trial reports, as
well as abstracts of PubMed articles to annotate them
automatically with concepts from appropriate ontologies.
The system enables researchers to locate relevant biologi-
cal data sets for integrative analyses.
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